173 related articles for article (PubMed ID: 10449550)
1. The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.
Hely MA; Morris JG; Traficante R; Reid WG; O'Sullivan DJ; Williamson PM
J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):300-7. PubMed ID: 10449550
[TBL] [Abstract][Full Text] [Related]
2. Spatial distribution of Parkinson's disease mortality in Spain, 1989-1998, as a guide for focused aetiological research or health-care intervention.
Pedro-Cuesta Jd; Rodríguez-Farré E; Lopez-Abente G
BMC Public Health; 2009 Dec; 9():445. PubMed ID: 19954536
[TBL] [Abstract][Full Text] [Related]
3. The Queensland Parkinson's Project: An Overview of 20 Years of Mortality from Parkinson's Disease.
Poortvliet PC; Gluch A; Silburn PA; Mellick GD
J Mov Disord; 2021 Jan; 14(1):34-41. PubMed ID: 33278869
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease inpatient mortality: Attention to sudden death.
de la Rosa T; Scorza FA
Clinics (Sao Paulo); 2024; 79():100366. PubMed ID: 38643608
[No Abstract] [Full Text] [Related]
5. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Hely MA; Morris JG; Reid WG; Trafficante R
Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
[TBL] [Abstract][Full Text] [Related]
6. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.
Hely MA; Reid WG; Adena MA; Halliday GM; Morris JG
Mov Disord; 2008 Apr; 23(6):837-44. PubMed ID: 18307261
[TBL] [Abstract][Full Text] [Related]
7. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
[TBL] [Abstract][Full Text] [Related]
8. Survival study of Parkinson disease in Olmsted County, Minnesota.
Elbaz A; Bower JH; Peterson BJ; Maraganore DM; McDonnell SK; Ahlskog JE; Schaid DJ; Rocca WA
Arch Neurol; 2003 Jan; 60(1):91-6. PubMed ID: 12533094
[TBL] [Abstract][Full Text] [Related]
9. Parkinsonism: onset, progression and mortality.
Hoehn MM; Yahr MD
Neurology; 1967 May; 17(5):427-42. PubMed ID: 6067254
[No Abstract] [Full Text] [Related]
10. Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
Bäckström D; Granåsen G; Domellöf ME; Linder J; Jakobson Mo S; Riklund K; Zetterberg H; Blennow K; Forsgren L
Neurology; 2018 Nov; 91(22):e2045-e2056. PubMed ID: 30381367
[TBL] [Abstract][Full Text] [Related]
11. What predicts mortality in Parkinson disease?: a prospective population-based long-term study.
Forsaa EB; Larsen JP; Wentzel-Larsen T; Alves G
Neurology; 2010 Oct; 75(14):1270-6. PubMed ID: 20921512
[TBL] [Abstract][Full Text] [Related]
12. Non-motor features of Parkinson disease.
Schapira AHV; Chaudhuri KR; Jenner P
Nat Rev Neurosci; 2017 Jul; 18(7):435-450. PubMed ID: 28592904
[TBL] [Abstract][Full Text] [Related]
13. Perceptions of Dysphagia Evaluation and Treatment Among Individuals with Parkinson's Disease.
Bartlett RS; Walters AS; Stewart RS; Wayment HA
Dysphagia; 2024 Jun; ():. PubMed ID: 38839626
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analyses evaluating the mortality risk associated with pimavanserin or other atypical antipsychotics in patients with Parkinson disease psychosis.
Isaacson SH; Pahwa R; Pagan F; Abler V; Truong D
Clin Park Relat Disord; 2024; 10():100256. PubMed ID: 38770047
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Cognitive Decline in Parkinson's Disease Using Clinical and DAT SPECT Imaging Features, and Hybrid Machine Learning Systems.
Hosseinzadeh M; Gorji A; Fathi Jouzdani A; Rezaeijo SM; Rahmim A; Salmanpour MR
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238175
[TBL] [Abstract][Full Text] [Related]
16. Post-Polio Syndrome Revisited.
Punsoni M; Lakis NS; Mellion M; de la Monte SM
Neurol Int; 2023 Apr; 15(2):569-579. PubMed ID: 37092507
[TBL] [Abstract][Full Text] [Related]
17. Relationship between motor dysfunction and chewing movement in patients with Parkinson's disease: A transversal study.
Sano T; Umemoto G; Fujioka S; Iwashita Y; Dotsu Y; Wada N; Tsuboi Y
Front Neurol; 2022; 13():1062134. PubMed ID: 36570461
[TBL] [Abstract][Full Text] [Related]
18. Systematic review for the prevention and management of falls and fear of falling in patients with Parkinson's disease.
Liu WY; Tung TH; Zhang C; Shi L
Brain Behav; 2022 Aug; 12(8):e2690. PubMed ID: 35837986
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease clinical milestones and mortality.
Gonzalez MC; Dalen I; Maple-Grødem J; Tysnes OB; Alves G
NPJ Parkinsons Dis; 2022 May; 8(1):58. PubMed ID: 35550520
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of atypical parkinsonian syndromes.
Lo RY
Tzu Chi Med J; 2022; 34(2):169-181. PubMed ID: 35465274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
